MIST
Milestone Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$158.11M
P/E Ratio
—
EPS
$-0.64
Beta
0.96
52W High
$3.06
52W Low
$1.00
50-Day MA
$1.67
200-Day MA
$1.87
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. The company is headquartered in Montral, Canada.
Fundamentals
| Revenue (TTM) | $1.78M |
| Gross Profit (TTM) | $1.77M |
| EBITDA | $-65.14M |
| Operating Margin | -9942.00% |
| Return on Equity | -456.90% |
| Return on Assets | -31.90% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $0.34 |
| Price-to-Book | 4.39 |
| Price-to-Sales (TTM) | 88.63 |
| EV/Revenue | 18.56 |
| EV/EBITDA | -1.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $124.50M |
| Float | $116.91M |
| % Insiders | 2.46% |
| % Institutions | 34.69% |
Historical Volatility
HV 10-Day
43.42%
HV 20-Day
53.68%
HV 30-Day
58.62%
HV 60-Day
98.37%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($6.33 target)
1
Strong Buy4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026